Chargement en cours...
Formulation Composition, Manufacturing Process, and Characterization of Poly(lactide-co-glycolide) Microparticles
Injectable long-acting formulations, specifically poly(lactide-co-glycolide) (PLGA) based systems, have been used to deliver drugs systematically for up to 6 months. Despite the benefits of using long-acting formulations, the development of clinical products and the generic versions of existing form...
Enregistré dans:
| Publié dans: | J Control Release |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7904638/ https://ncbi.nlm.nih.gov/pubmed/33148404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.10.044 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|